Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy

BMC Cancer. 2020 Feb 24;20(1):151. doi: 10.1186/s12885-020-6654-5.

Abstract

Background: Alteration in gut microbiota has been recently linked with childhood leukemia and the use of chemotherapy. Whether the perturbed microbiota community is restored after disease remission and cessation of cancer treatment has not been evaluated. This study examines the chronological changes of gut microbiota in children with acute lymphoblastic leukemia (ALL) prior to the start-, during-, and following cessation of chemotherapy.

Methodology: We conducted a longitudinal observational study in gut microbiota profile in a group of paediatric patients diagnosed with ALL using 16 s ribosomal RNA sequencing and compared these patients' microbiota pattern with age and ethnicity-matched healthy children. Temporal changes of gut microbiota in these patients with ALL were also examined at different time-points in relation to chemotherapy.

Results: Prior to commencement of chemotherapy, gut microbiota in children with ALL had larger inter-individual variability compared to healthy controls and was enriched with bacteria belonging to Bacteroidetes phylum and Bacteroides genus. The relative abundance of Bacteroides decreased upon commencement of chemotherapy. Restitution of gut microbiota composition to resemble that of healthy controls occurred after cessation of chemotherapy. However, the microbiota composition (beta diversity) remained distinctive and a few bacteria were different in abundance among the patients with ALL compared to controls despite completion of chemotherapy and presumed restoration of normal health.

Conclusion: Our findings in this pilot study is the first to suggest that gut microbiota profile in children with ALL remains marginally different from healthy controls even after cessation of chemotherapy. These persistent microbiota changes may have a role in the long-term wellbeing in childhood cancer survivors but the impact of these changes in subsequent health perturbations in these survivors remain unexplored.

Keywords: Bacteroides; Bacteroidetes; Chemotherapy; Childhood acute lymphoblastic leukemia; Microbiome; Microbiota dysbiosis.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bacteria / classification*
  • Bacteria / genetics
  • Case-Control Studies
  • Child
  • Child, Preschool
  • Feces / microbiology
  • Female
  • Gastrointestinal Microbiome / genetics*
  • Humans
  • Male
  • Phylogeny
  • Pilot Projects
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / microbiology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • RNA, Ribosomal, 16S / genetics*
  • Sequence Analysis, DNA / methods

Substances

  • RNA, Ribosomal, 16S